TP53 and neoplasm: The study identified MSI tumours with MLH1/PMS2 defects, and high-grade POLE-wildtype/MSS tumours exhibited high immunogenicity, characterized by dense T-cell infiltration. Additionally, high Treg density was associated with a poor prognosis in p53-mutant EC.